Treating Varicose Veins like never before

LEARN MORE

Treating Varicose Veins like never before

LEARN MORE

Treating Varicose Veins like never before

LEARN MORE


New Paradigm

Thanks to its proprietary technology, for the first time in history, I-VASC can safely remove blood from the Vein portion where treatment needs to be performed

Safe

The drug is injected in an empty portion of vein, totally under control and can be RECOVERED before the procedure ends avoiding any possible side effect

Effective

Without blood and its dilutive effect, quantity and concentration of drug to be injected is significantly less than any other sclerotherapy ablation increasing efficacy regardless vein’s size

Proprietary

Technology is surrounded with strong Intellectual Property portfolio covering both device and method

More than 170 Millions people globally suffer from CVI*, Chronic venous insufficiency, which is often associated with varicose veins, a twisted and enlarged veins close to the surface of the skin. They can occur almost anywhere, but most commonly occur in the legs.

i vasc varicose veins treatment

Approximately 23% of adults in the United States have varicose veins. This figure rises to 80% for men and 85% for women if reticular veins and spider telangiectasias are included*

*Piazza G. Varicose veins. Circulation. 2014 Aug 12. 130 (7):582-7. [Medline]. )

Blood Circulation

It’s considered a limitation for sclerotherapeutic and endovascular treatments, decreasing success rates and causing associated complications.
For the first time, Velex™, thanks to Mt-Vess™
technology, can remove blood and treat an empty portion of the vein



Step 1


BLOOD DISPLACEMENT

Step 2


DRUG
RELEASE

Step 3


DRUG
RECOVERY



  • A New and Standardized way to perform Sclerotherapy

  • Effective on all Vein’s Size

  • Reduces Procedural Time and Complications

  • Velex™  is currently for Investigational Research Use Only. Regulatory approval is anticipated in 2021

Learn More
Unmatched Performance & Usability


NEWS


Scientific Board

Another great milestone achieved, we are honored to have PROF. SERGIO GIANESINI, FROM ITALY PROF. WILLY CHI, FROM USA P...

I-VASC Awards

We've been awarded several times for our new disruptive technology. These are the most important ones I-VASC Incubated In...

Would You Like To get more details about I-VASC New Vascular Device Technology? Contact Us



Our Team is ready to address all your questions
Contact Us